Rayence Co. Ltd (228850) - Total Liabilities

Latest as of December 2025: ₩23.85 Billion KRW ≈ $16.16 Million USD

Based on the latest financial reports, Rayence Co. Ltd (228850) has total liabilities worth ₩23.85 Billion KRW (≈ $16.16 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Rayence Co. Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how Rayence Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Rayence Co. Ltd to evaluate short-term liquidity relative to the company's equity base.

Rayence Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Rayence Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
Nestcon Bhd
KLSE:0235
Malaysia RM635.15 Million
Gateway Real Estate AG
XETRA:GTY
Germany €1.18 Billion
Golden Energy Offshore Services AS
OL:GEOS
Norway Nkr1.15 Billion
FALCON METALS LTD
F:E47
Germany €883.21K
Jinhui Shipping and Transportation Limited
OL:JIN
Norway Nkr166.22 Million
Cheviot Company Limited
NSE:CHEVIOT
India Rs645.38 Million
Kawan Food Bhd
KLSE:7216
Malaysia RM53.88 Million
Jayant Agro Organics Limited
NSE:JAYAGROGN
India Rs3.23 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Rayence Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 228850 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 14.95 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.10 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.09 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Rayence Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Rayence Co. Ltd (2015–2025)

The table below shows the annual total liabilities of Rayence Co. Ltd from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 ₩23.85 Billion
≈ $16.16 Million
-2.84%
2024-12-31 ₩24.55 Billion
≈ $16.64 Million
-33.09%
2023-12-31 ₩36.69 Billion
≈ $24.86 Million
-1.51%
2022-12-31 ₩37.25 Billion
≈ $25.24 Million
-9.63%
2021-12-31 ₩41.22 Billion
≈ $27.94 Million
+12.78%
2020-12-31 ₩36.55 Billion
≈ $24.77 Million
-3.24%
2019-12-31 ₩37.78 Billion
≈ $25.60 Million
+96.06%
2018-12-31 ₩19.27 Billion
≈ $13.06 Million
-2.74%
2017-12-31 ₩19.81 Billion
≈ $13.42 Million
-20.56%
2016-12-31 ₩24.94 Billion
≈ $16.90 Million
-26.79%
2015-12-31 ₩34.06 Billion
≈ $23.08 Million
--

About Rayence Co. Ltd

KQ:228850 Korea Medical Devices
Market Cap
$70.38 Million
₩103.86 Billion KRW
Market Cap Rank
#20668 Global
#1137 in Korea
Share Price
₩6600.00
Change (1 day)
-1.64%
52-Week Range
₩4895.00 - ₩6990.00
All Time High
₩20930.72
About

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-… Read more